DAPASUG-ST-100 - Sitagliptin Phosphate Monohydrate 100mg + Dapagliflozin Propanediol Monohydrate 10mg | Intralife Pharmaceuticals
DIASAGE
FeaturedTop

DAPASUG-ST-100

MRP: 2,200

Packaging: 10x10

Pack Type: tablet

Composition:

Sitagliptin Phosphate Monohydrate 100mg + Dapagliflozin Propanediol Monohydrate 10mg

Indication:

A highly potent, reversible and selective sodium-glucose contransporter-2 inhibitor indicated worldwide for the treatment of Type 2 diabetes

Description:

Sitagliptin Phosphate Monohydrate 100mg + Dapagliflozin Propanediol Monohydrate 10mg is a combination oral antidiabetic medication designed to improve glycemic control in adults with type 2 diabetes mellitus. Sitagliptin is a DPP-4 inhibitor that increases incretin levels, enhancing insulin secretion and decreasing glucagon levels. Dapagliflozin is an SGLT2 inhibitor that helps lower blood glucose by promoting glucose excretion through urine.

This dual-action formula targets different pathways to provide effective blood sugar regulation. It is typically prescribed alongside diet and exercise to enhance glycemic control and may be part of a broader diabetes management plan.

Tags:

Type 2 Diabetes Oral Antidiabetics Combination Therapy DPP-4 Inhibitor SGLT2 Inhibitor Prescription Medicine
  • Dual mechanism for effective blood glucose control
  • Reduces HbA1c levels
  • Aids in weight management through glucose excretion
  • Convenient once-daily oral administration
  • Improves insulin sensitivity and pancreatic function

Usage Information

Dosage

Typical Dose: One tablet once daily, preferably at the same time each day. Route: Oral With or without food: Can be taken with or without meals. Important: Follow your doctor’s exact dosage instructions. Do not adjust dose without consultation.

Side Effects

Urinary tract infections Nasopharyngitis Headache Dizziness Hypoglycemia (when used with insulin or sulfonylureas) Dehydration Genital fungal infections Increased urination Seek immediate medical attention if experiencing severe allergic reactions, ketoacidosis symptoms, or signs of urinary tract infections.

Contraindications

Type 1 diabetes mellitus Diabetic ketoacidosis Severe renal impairment or end-stage renal disease Hypersensitivity to Sitagliptin, Dapagliflozin, or any excipients Active bladder cancer (for dapagliflozin) Severe hepatic impairment (use with caution)

Availability

Sitagliptin Dapagliflozin tablets DPP-4 and SGLT2 inhibitor combination Sitagliptin 100mg + Dapagliflozin 10mg Type 2 diabetes dual therapy Antidiabetic combination tablets Blood sugar control medicine Oral diabetes medication Diabetes management tablets

Sitagliptin 100mg + Dapagliflozin 10mg | Intralife Pharmaceuticals | Intralife